Klinefelter's syndrome (KS) is primary male hypogonadism caused by developmental testicular defects related to an underlying chromosomal abnormality. The usual karyotype in KS is 47, XXY(classical form), but 46, XY/47, XXYmosaicism is detected in approximately 10%of cases (1) . The frequency of KS is about 1/500 males at conception, but half of the KS fetuses are lost during pregnancy, so the syndrome is present in 1/1,000 live male newborns. The typical endocrine derangements observed in patients with KSinclude decreased secretion of androgens (testosterone, dihydrotestosterone, etc), increased plasma gonadotropins, and gynecomastia/male hypogonadism resulting from the relatively strengthened actions exerted by estrogens (estradiol, etc) compared with the actions exerted by androgens as known by increased estradiol/testosterone ratios. Another characteristic of KSis the concomitant occurrence of various autoimmunediseases such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and thyroid autoimmune diseases. In this journal, Takeuchi et al (2) reported mixed connective tissue disease (MCTD), another associated autoimmunedisease, in a case of KS.
See also p 875.
Although there have not yet been any adequate explanations for the concomitant occurrence of autoimmunediseases with KS, our understanding of this issue may be enhanced if we consider the following: 1. The anti-autoimmune effects of androgens have been more definitively demonstrated in recent years both clinically and experimentally; 2. It is well known that sexual dimorphism or feminine predominance is generally present in autoimmune diseases, including rheumatoid arthritis, SLE, primary biliary cirrhosis, Graves' disease and Hashimoto's thyroiditis (3); and 3. Sex hormones exercise their sex-specific functions based on the biological balance of counterpart effects betweenandrogens and estrogens. Acceptance of the theory that gonadal steroids regulate immunesystem function including the genesis of autoimmunity is growing (3, 4) , and many investigators have reported animal experiments showing that administration of androgens suppresses the development of autoimmune diseases such as type easily lead to reduced production of IL-2, the most potent amplifier in the immunecytokine network. These effects of androgens on cytokine production naturally lead to an attenuation of immune responses. Moreover,androgensalso act on the B cell system. While there is no direct action on peripheral B cells per se, androgens deplete pre-B cells in the bone marrow and diminish peripheral B cell numbers, ultimately suppressing autoantibody production (4). As a matter of fact, Jefferies (8) has proposed that the combination of three factors (hypoandrogenism, mild adrenocortical insufficiency, and mycoplasmainfection) is a possible cause of rheumatoid arthritis. If mild adrenocortical insufficiency is present, wecannot sufficiently respondto stress or sufficiently suppress early autoimmunereactions. It is a compelling idea to consider that autoimmunediseases maybe chronically elicited by long-standing exposure of the host to antigens or infectious agents in the presence of an insidius adrenocortical insufficiency together with hypoandrogenism. On this point, the report from Takeuchi et al (2) is indeed excellent because it proved the presence of mild adrenocortical insufficiency in a patient based on reliable data that verified increased ACTH secretion, decreased circulatory dehydroepiandrosterone sulfate, and decreased urinary free cortisol. Thus, their report may serve as an important landmark in the understanding of the mechanisms of autoimmunity in KS. More than three decades ago, diabetes mellitus (DM)was already reported as a disease frequently associated with KS (9-1 1), but the reports from that decade rarely distinguished DMtypes between type 1 (caused by autoimmunity) and type 2 (caused by insulin resistance). Nowlooking back at the past literature, the majority of KSpatients reported to have DM seem to have had type 2 DMpresenting with hyperglycemia associated with secretion of considerable amounts of insulin (insulin resistance). Nonetheless, type 1 DMcan also occur in the presence of a sufficient causality related to autoimmunity based on hypoandrogenism, as mentioned above. There are mutual relationships between androgen and insulin actions ( 12) . In obesity and type 2 diabetes, hyperinsulinemia due to insulin resistance is associated with decreased testosterone levels, while hypogonadal males are frequently hyperinsulinemic or insulin resistant. For the latter, the treatment with testosterone induces reduction of insulin and leptin levels in parallel with a decrease of fat tissue mass. The mechanismsof both causal relationships (hyperinsulinemia inducing hypotestosteronemia and vice versa) are not clearly knownand await further elucidation.
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